Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

188.87 -0.18 (-0.10%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The Looming Spectre: What Could Puncture the Stock Market's AI-Driven Bubble?
As October 2025 unfolds, a palpable tension hangs over global financial markets. Despite record highs in major indices like the Nasdaq 100 (NASDAQ: NDX) and the FTSE 100 (LSE: UKX), a growing chorus of... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Federal Reserve Navigates Rate Cuts Amidst Lingering Inflationary Shadows
The Federal Reserve has embarked on a delicate balancing act, initiating interest rate cuts in 2025 to bolster a softening labor market while grappling with persistent inflation concerns among some of... 
Via MarketMinute
Topics Derivatives Economy Stocks
FDA Expands Johnson & Johnson Ulcerative Colitis Drug Approval To Pediatric Patients
FDA approves Johnson & Johnson's Simponi for children with moderate to severe ulcerative colitis, supported by positive Phase 3 trial results. 
Via Benzinga
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump
One of these stocks lost about a quarter of its value in a single month. 
Via The Motley Fool
Topics Government Stocks World Trade
Why AbbVie and Johnson & Johnson Could Outperform Pfizer
Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential 
Via MarketBeat
Worried About a Recession? 2 Stocks to Buy Now to Prepare Your Portfolio
These two market leaders have increased their dividends for a combined 115 years. 
Via The Motley Fool
Topics Economy Government Supply Chain
Congresswoman Violates STOCK Act With Late Trade Disclosures: Purchases Include Bitcoin ETF
As legislation in Congress heats up to ban elected officials from buying and selling stocks, several members have violated the STOCK Act in 2025, failing to disclose their transactions in a timely... 
Via Benzinga
Healthcare Sector Defies Broader Market Swings, Leads S&P 500 Momentum on October 7, 2025
On a day where the broader S&P 500 and Nasdaq Composite indices soared to new all-time record highs, the S&P 500 Healthcare sector presented a compelling, albeit nuanced, narrative of market leadership... 
Via MarketMinute
Topics Artificial Intelligence ETFs Intellectual Property
Johnson & Johnson Reportedly Ordered To Pay $966M To Family Of Woman Who Died Of Rare Cancer Allegedly Associated With Its Talc
According to a Reuters report, a Los Angeles Jury has ordered the company to pay $16 million in compensatory damages and $950 million in punitive damages. 
Via Stocktwits
Topics Bankruptcy Death Lawsuit
Top S&P500 movers in Tuesday's pre-market session
The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today. 
Via Chartmill
1 Reason I'm Watching Intuitive Surgical Stock in 2026
The surgical robotics pioneer could cement its leading position for years to come. 
Via The Motley Fool
Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
From Johnson & Johnson
Via Business Wire
Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again
While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again. 
Via Benzinga
U.S. Labor Market Stalls: Moody's Reports 'Essentially No Job Growth' Amidst Government Shutdown, Raising Recession Fears
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025.... 
Via MarketMinute
Topics Artificial Intelligence Credit Cards Economy
Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants
Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief. 
Via MarketBeat
Topics Government Supply Chain World Trade
Navigating the Storm: Essential Strategies to Avoid 'Bag Holder' Status in Volatile Markets
The financial markets, as of October 4, 2025, continue to be characterized by a significant degree of volatility, presenting both opportunities and perilous traps for investors. In such an environment,... 
Via MarketMinute
Topics ETFs Economy
Market Defies D.C. Gridlock: S&P 500 and Dow Jones Soar to Record Highs Amidst Government Shutdown
The U.S. financial markets are currently presenting a perplexing paradox. As of October 4, 2025, both the S&P 500 and Dow Jones Industrial Average (DJIA) have surged to unprecedented record highs,... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
US Government Shutdown Casts Global Shadow: Economic Data Delays Fuel Investor Uncertainty
The United States government is currently in the throes of a shutdown, commencing at 12:01 a.m. EDT on October 1, 2025, after a congressional impasse prevented the passage of appropriations legislation... 
Via MarketMinute
Topics Bonds Economy Government
Healthcare Stands Strong: A Pillar in the S&P 500 Amidst Tech Sector Retreat
As the S&P 500 navigates a dynamic market on October 3, 2025, the Healthcare sector has emerged as a steadfast performer, demonstrating remarkable resilience and contributing significantly to the... 
Via MarketMinute
Topics Economy Intellectual Property Stocks
Data Blackout: Government Shutdown Leaves Fed Flying Blind Amidst Economic Crossroads
The U.S. economy finds itself at a critical juncture, navigating persistent inflation and a cooling labor market, while simultaneously grappling with the immediate and profound implications of an... 
Via MarketMinute
Topics Economy Energy Regulatory Compliance
Johnson & Johnson's Options Frenzy: What You Need to Know
 
Via Benzinga
Coinbase To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
This Johnson & Johnson Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
 
Via Benzinga
Federal Shutdown Stalls Inflation Data, Blurring Fed's Path and Rattling Markets
A federal government shutdown has once again cast a shadow over the U.S. financial landscape, leading to an indefinite delay in the publication of critical U.S. inflation data. This unexpected halt in... 
Via MarketMinute
Topics Credit Cards Economy
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount. 
Via Benzinga
Vanguard Sounds Alarm: Is the US Stock Market 'Priced for Perfection'?
Vanguard, one of the world's largest investment management firms, has issued a stark warning regarding the U.S. stock market, cautioning that it is currently "priced for perfection." This assessment... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design
London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented... 
Via TokenRing AI
Topics Artificial Intelligence
Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes
Paris, France – October 2, 2025 – Nanobiotix (NASDAQ: NBTX) witnessed a significant surge in its stock price today, jumping 11.6%, following the announcement of highly encouraging initial data from a... 
Via MarketMinute
Tesla Stock Surges Nearly 2% In Thursday Pre-Market: What's Going On?
Tesla Inc. stock climbed 1.86% during Thursday pre-market trading session after CEO Elon Musk reached an unprecedented financial milestone. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.